Skip to main content
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
1.210
-0.030 (-2.42%)
At close: Jul 2, 2024, 3:51 PM
1.240
+0.030 (2.48%)
After-hours: Jul 2, 2024, 4:10 PM EDT

OKYO Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Year
 Current2022202120202019
Market Capitalization
4047---
Enterprise Value
3845-3-7-0
PE Ratio
--3.55---
PB Ratio
-22.98-22.98---
P/FCF Ratio
-6.13-6.13---
P/OCF Ratio
-6.13-6.13---
EV/EBITDA Ratio
-3.44-3.440.432.020.13
EV/EBIT Ratio
-3.44-3.440.432.010.13
EV/FCF Ratio
-5.89-5.890.494.230.17
Debt / Equity Ratio
-1.08-1.08-0.02-0.23
Debt / EBITDA Ratio
-0.17-0.17--0.03-0.02
Debt / FCF Ratio
-0.29-0.29--0.06-0.03
Quick Ratio
0.640.642.604.080.69
Current Ratio
0.720.723.174.090.80
Interest Coverage
-136.39-136.39--3007.46-1398.26
Return on Equity (ROE)
-2968.50%-2968.50%-131.40%-129.50%-
Return on Assets (ROA)
-279.30%-279.30%-95.30%-87.20%-
Return on Capital (ROIC)
-8146.58%-8146.58%-210.95%-62.13%1415.40%
Earnings Yield
-33.00%-28.13%---
FCF Yield
-19.15%-16.32%---
Buyback Yield / Dilution
-29.71%-29.71%---
Total Shareholder Return
-29.71%-29.71%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).